Description
AFANAT 40 Tablet 28’s is a potent medication designed for the management of certain types of cancer. Each tablet contains 40mg of the active ingredient Afatinib, a kinase inhibitor that targets epidermal growth factor receptor (EGFR) mutations. This targeted therapy helps inhibit the growth and spread of cancer cells, providing a crucial treatment option for patients with advanced non-small cell lung cancer (NSCLC) and other EGFR-mutated tumors. AFANAT 40 Tablet 28’s is an essential component in comprehensive cancer care, offering hope and improved outcomes for those battling this disease. Always consult with a healthcare provider for proper dosage and administration.
Reviews
There are no reviews yet.